Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature

[1] Oelke M(2013)EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction Eur Urol 64 118-140

[2] Bachmann A(2000)The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56 3-6

[3] Descazeaud A(2012)EAU guidelines on laser technologies Eur Urol 61 783-795

[4] Kirby RS(2008)The evolution of KTP laser vaporization of the prostate Yonsei Med J 49 189-199

[5] Herrmann TRW(2013)GreenLight XPS 180 W vs HPS 120 W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study Urology 81 853-858

[6] Liatsikos EN(2014)180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH study Eur Urol 65 931-942

[7] Nagele U(2014)An European multicenter randomized noninferiority trial comparing 180-W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-months results of the GOLIATH-study J Urol 82 334-337

[8] Sountoulides P(2012)Photoselective vaporization of the prostate using the 180 W lithium triborate laser ANZ J Surg 1 42-45

[9] Tsakiris P(2013)Early experience photoselective vaporisation of the prostate using the 180 W lithium triborate and comparison with the 120 W lithium triborate laser Prostate Int 61 600-607

[10] Ben-Zvi T(2012)180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures Eur Urol 7 370-377

[1] Oelke M(2013)EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction Eur Urol 64 118-140

[2] Bachmann A(2000)The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56 3-6

[3] Descazeaud A(2012)EAU guidelines on laser technologies Eur Urol 61 783-795

[4] Kirby RS(2008)The evolution of KTP laser vaporization of the prostate Yonsei Med J 49 189-199

[5] Herrmann TRW(2013)GreenLight XPS 180 W vs HPS 120 W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study Urology 81 853-858

[6] Liatsikos EN(2014)180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH study Eur Urol 65 931-942

[7] Nagele U(2014)An European multicenter randomized noninferiority trial comparing 180-W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-months results of the GOLIATH-study J Urol 82 334-337

[8] Sountoulides P(2012)Photoselective vaporization of the prostate using the 180 W lithium triborate laser ANZ J Surg 1 42-45

[9] Tsakiris P(2013)Early experience photoselective vaporisation of the prostate using the 180 W lithium triborate and comparison with the 120 W lithium triborate laser Prostate Int 61 600-607

[10] Ben-Zvi T(2012)180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures Eur Urol 7 370-377